Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis

Pain

Volumn 32, Issue 1, 1988, Pages 21-26

  Vaerøy, Henning ^a   Helle, Robert ^a   Førre, Øystein ^a   Kåss, Erik ^a   Terenius, Lars ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Fibromyalgia; Raynaud's phenomenon; Smoking; Substance P

Indexed keywords

NEUROPEPTIDE; SUBSTANCE P;

ADULT; CEREBROSPINAL FLUID; CLINICAL ARTICLE; FEMALE; FIBROMYALGIA; HUMAN; RAYNAUD PHENOMENON; SMOKING;

ADULT; FEMALE; FIBROMYALGIA; HUMAN; RAYNAUD'S DISEASE; SMOKING; SUBSTANCE P; SUPPORT, NON-U.S. GOV'T;

EID: 0023919037     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3959(88)90019-X     Document Type: Article

References (17)

1. Fibrositis: evolution of an enigma
2. Neuropeptides in human cerebrospinal fluid
3. Immunofluorescent detection of IgG at the dermal-epidermal junction in patients with apparent primary fibrositis syndrome
4. A prospective evaluation of 118 patients with the fibromyalgia syndrome: prevalence of Raynaud's phenomenon, Sicca symptoms, ANA, low complement, and Ig deposition at the dermal-epidermal junction
5. Substance P as neurogenic mediator of antidromic vasodilatation and neurogenic plasma extravasation
6. Postocclusive cutaneous vasodilatation mediated by substance P
7. Opioid control of the function of primary afferent substance P fibres
8. Sleep related myoclonus in rheumatic pain modulation disorder (fibrositis syndrome) and in excessive daytime somnolence
9. Involvement of the sympathetic nervous system in pain
10. Influence of substance P on nociception and stress
11. Role of substance P as a sensory transmitter in spinal cord and symphatic ganglia substance P in the nervous system
12. Substance P
13. Substance P mechanism in cluster headache: evaluation in plasma and cerebrospinal fluid
14. Fibrositis as a disorder of pain modulation
15. Capsaicin-evoked release of substance P from primary sensory neurons
16. Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo
17. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls